Patients from January 2015 to August 2019 at Zhongnan hospital of Wuhan University(n=408)
healthy control group(n=105)
patients with coronary atherosclerotic heart desease(n=103)
To evaluate the relationship between cardiac-related clinical outcomes and leukemia
patients with a history of known cardiomyopathy or congestive heart failure or other malignancies were excluded
